Skip to main content

Table 3 Adverse events according to treatment allocation

From: A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology

 

OK432

BCG

Control

Number of participants

1

3

3

Any adverse event

1

3

4

 Grade 1

-

-

2

 Grade 2

-

1

1

 Grade 3

1

2

1

 Grade 4/5

-

-

-

Serious adverse event

1

1

1

Specific events

   

 Systemic inflammatory response

1

3

-

 Pleural infection

-

-

2

 Chest wall pain

-

-

1

 Upper respiratory tract infection

-

-

1